Premium
Stem cell antigen‐1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts
Author(s) -
Epting Conrad L.,
King Frank W.,
Pedersen Anissa,
Zaman Jessica,
Ritner Carissa,
Bernstein Harold S.
Publication year - 2008
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.21500
Subject(s) - myocyte , enzyme , microbiology and biotechnology , cell , antigen , chemistry , stem cell , insulin , biochemistry , biology , endocrinology , genetics
Stem cell antigen‐1 (Sca‐1, Ly6A/E) is a glycosylphosphotidylinositol‐anchored protein that identifies many tissue progenitor cells. We originally identified Sca‐1 as a marker of myogenic precursor cells and subsequently demonstrated that Sca‐1 regulates proliferation of activated myoblasts, suggesting an important role for Sca‐1 in skeletal muscle homeostasis. Beyond its functional role in regulating proliferation, however, little is known about the mechanism(s) that drive Sca‐1‐mediated events. We now report that lipid microdomain organization is essential for normal myogenic differentiation, and that Sca‐1 constitutively localizes to these domains during myoblast proliferation and differentiation. We also demonstrate that Sca‐1 associates with insulin degrading enzyme (IDE), a catalytic protein responsible for the cleavage of mitogenic peptides, in differentiating myoblasts. We show that chemical inhibition of IDE as well as RNAi knockdown of IDE mRNA recapitulates the phenotype of Sca‐1 interference, that is, sustained myoblast proliferation and delayed myogenic differentiation. These findings identify the first signaling protein that physically and functionally associates with Sca‐1 in myogenic precursor cells, and suggest a potential pathway for Sca‐1‐mediated signaling. Future efforts to manipulate this pathway may lead to new strategies for augmenting the myogenic proliferative response, and ultimately muscle repair. J. Cell. Physiol. 217: 250–260, 2008. © 2008 Wiley‐Liss, Inc.